ATE345787T1 - Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie - Google Patents

Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie

Info

Publication number
ATE345787T1
ATE345787T1 AT02712381T AT02712381T ATE345787T1 AT E345787 T1 ATE345787 T1 AT E345787T1 AT 02712381 T AT02712381 T AT 02712381T AT 02712381 T AT02712381 T AT 02712381T AT E345787 T1 ATE345787 T1 AT E345787T1
Authority
AT
Austria
Prior art keywords
sup
dysuria
medication
producing
treatment
Prior art date
Application number
AT02712381T
Other languages
English (en)
Inventor
Masao Miyagawa
Takeshi Watanabe
Motoaki Saito
Bang Luu
Masashi Yamada
Hiroto Suzuki
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of ATE345787T1 publication Critical patent/ATE345787T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02712381T 2001-02-19 2002-02-15 Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie ATE345787T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001041587A JP3836684B2 (ja) 2001-02-19 2001-02-19 排尿障害治療剤

Publications (1)

Publication Number Publication Date
ATE345787T1 true ATE345787T1 (de) 2006-12-15

Family

ID=18904009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02712381T ATE345787T1 (de) 2001-02-19 2002-02-15 Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie

Country Status (7)

Country Link
US (1) US6906107B2 (de)
EP (1) EP1368014B1 (de)
JP (1) JP3836684B2 (de)
AT (1) ATE345787T1 (de)
CA (1) CA2438509C (de)
DE (1) DE60216239T8 (de)
WO (1) WO2002066024A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
WO2004087630A1 (en) * 2003-03-28 2004-10-14 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
US20080125495A1 (en) 2004-11-25 2008-05-29 Meiji Dairies Corporation Ameliorant For Renal Insufficiency
EP2196200A1 (de) * 2005-01-18 2010-06-16 Meiji Dairies Corporation Cyclohexenonderivat zur Prävention oder Behandlung von Hypästhesie oder durch Diabetes verursachter Hyperästhesie
US20080312336A1 (en) * 2005-05-26 2008-12-18 Keisuke Satoh Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder
WO2013147072A1 (ja) * 2012-03-29 2013-10-03 大鵬薬品工業株式会社 3-(15-ヒドロキシペンタデシル)-2,4,4-トリメチル-2-シクロヘキセン-1-オンの共結晶
JP5566521B1 (ja) * 2013-09-27 2014-08-06 大鵬薬品工業株式会社 膀胱・尿道協調不全改善剤
US20170035705A1 (en) * 2015-08-04 2017-02-09 Taiho Pharmaceutical Co., Ltd. Detrusor hyperactivity with impaired contractility ameliorating agent
JP6894555B1 (ja) * 2020-07-03 2021-06-30 大鵬薬品工業株式会社 排尿症状治療剤
JP2022013721A (ja) * 2020-07-03 2022-01-18 大鵬薬品工業株式会社 排尿症状治療剤
BR112023001832A2 (pt) * 2020-08-07 2023-02-23 Taiho Pharmaceutical Co Ltd Composto cicloalquenona ou sal do mesmo
WO2023153422A1 (ja) * 2022-02-09 2023-08-17 大鵬薬品工業株式会社 シクロヘキセノン化合物の結晶形

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6228893B1 (en) * 1997-08-13 2001-05-08 Meiji Milk Products Co., Ltd. Cyclohexenone long-chain alcohol and medicament containing same

Also Published As

Publication number Publication date
DE60216239T2 (de) 2007-03-08
CA2438509A1 (en) 2002-08-29
WO2002066024A1 (en) 2002-08-29
EP1368014B1 (de) 2006-11-22
US6906107B2 (en) 2005-06-14
CA2438509C (en) 2010-04-20
DE60216239T8 (de) 2007-06-21
JP3836684B2 (ja) 2006-10-25
EP1368014A1 (de) 2003-12-10
JP2002241271A (ja) 2002-08-28
DE60216239D1 (de) 2007-01-04
US20040132829A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
EP1725536B8 (de) Imidazolinderivate mit cb1-antagonistischer wirkung
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE355056T1 (de) Jasmonate enthaltende therapeutische zusammensetzungen für die behandlung von krebs
EP1362846A4 (de) Aminoethanolderivate
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
ATE345787T1 (de) Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
DE69811905D1 (de) Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
EP1634874A4 (de) Imidazolidinderivate
ATE305777T1 (de) Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation
SE0101324D0 (sv) New process
ATE184793T1 (de) Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8
ATE270884T1 (de) Langkettiger cyclohexenonalkohol zur behandlung von amyotropher lateraler sklerose
DE60238666D1 (de) Cyclohexenon derivate zur behandlung der diabetischen neuropathie
NO20070421L (no) Radiosensitiviserende middel
DE60140685D1 (de) Stemzelldifferenzierung induzierende promoter
DE60228968D1 (de) Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
NZ594754A (en) Biologically active compounds derived from Centipeda cunninghamii
ATE247903T1 (de) Fungizide zusammensetzung enthaltend ein n- benzoyl-n'-phenyl-harnstoff derivat
DE602005027246D1 (de) Mittel zur linderung von niereninsuffizienz
DE69528984T2 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
TH64685A (th) 1-เมทิล-2-(4-อะมิไดโนเฟนิลามิโนเมทิล)-เบนซิมิดาซอล-5-อิล-คาร์บอกซิลิกแอซิด-(n-2-ฟิริดิล-n-2-ไฮดรอกซีคาร์บอนิลเอทิล)-เอมีด ชนิดยาต้นแบบใหม่ การเตรียมสารนั้นและการใช้เป็นสารผสมทางเภสัชกรรม
UA84737C2 (ru) Производные имидазолина с антагонистической активностью относительно cb1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties